gene_symbol
CD3E
hgnc_id
HGNC:1674
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Blinatumomab binds CD3 on T cells to recruit and activate them against CD19+ cells; T cells (CD3+) are not killed—activated T cells kill CD19+ targets via perforin/granzyme.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Binds the epsilon chain within the CD3-TCR complex on T cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06237192
disease_id_num_tar_ref
2159
drug_id_num_tar_ref
5766